Japan Projects Regenerative-Medicine Market At $17 Billion By 2030
This article was originally published in PharmAsia News
Executive Summary
Japan projects its market for regenerative medicine to be worth more than $17 billion in 2030, in part as a result of increased demand for stem cells for producing a variety of products.